| Literature DB >> 27135319 |
Yuning Chen1, Dening Ye2, Michael A Held3, Maura C Cannon4, Tui Ray5, Prasenjit Saha6, Alexandra N Frye7, Andrew J Mort8, Marcia J Kieliszewski9.
Abstract
Extensins are members of the cell wall hydroxyproline-rich glycoprotein (HRGP) superfamily that form covalently cross-linked networks in primary cell walls. A knockout mutation in EXT3 (AT1G21310), the gene coding EXTENSIN 3 (EXT3) in Arabidopsis Landsberg erecta resulted in a lethal phenotype, although about 20% of the knockout plants have an apparently normal phenotype (ANP). In this study the root cell wall HRGP components of wild-type, ANP and the ext3 mutant seedlings were characterized by peptide fractionation of trypsin digested anhydrous hydrogen fluoride deglycosylated wall residues and by sequencing using LC-MS/MS. Several HRGPs, including EXT3, were identified in the wild-type root walls but not in walls of the ANP and lethal mutant. Indeed the ANP walls and walls of mutants displaying the lethal phenotype possessed HRGPs, but the profiles suggest that changes in the amount and perhaps type may account for the corresponding phenotypes.Entities:
Keywords: Arabidopsis root; Extensin 3; LRX; PRP4; cell wall; hydroxyproline-rich glycoprotein; proteomics
Year: 2015 PMID: 27135319 PMCID: PMC4844335 DOI: 10.3390/plants4010085
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Amino Acid Composition (mole %) of the Root Cell Wall (CW), Insoluble Cell Wall Pellet Remaining after Treatment with HF (HFI), Trypsin (TI HFI) and Pronase (PI HFI).
| Amino Acid | WT | WT | WT | WT | ANP4 | ANP4 | ANP4 | ANP4 | ANP10 | ANP10 | ANP10 | ANP10 | MT | MT | MT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CW | HFI | TI HFI | PI HFI | CW | HFI | TI HFI | PI HFI | CW | HFI | TI HFI | PI HFI | CW | HFI | TI HFI | |
| Asp | 6 | 1 | 2 | 1 | 6 | 6 | 4 | 4 | 6 | 4 | 1 | 1 | 7 | 5 | 5 |
| Glu | 6 | 3 | 2 | 2 | 5 | 4 | 3 | 3 | 6 | 3 | 2 | 2 | 7 | 2 | 4 |
| Ser | 10 | 14 | 17 | 18 | 11 | 9 | 13 | 18 | 11 | 8 | 15 | 19 | 10 | 2 | 7 |
| Gly | 11 | 11 | 12 | 13 | 14 | 12 | 17 | 23 | 12 | 10 | 12 | 16 | 12 | 18 | 20 |
| His | 2 | 2 | 3 | 2 | 2 | 3 | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 3 | 4 |
| Arg | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 3 | 2 | 2 | 3 | 5 | 2 |
| Thr | 3 | 5 | 4 | 3 | 3 | 5 | 3 | 3 | 3 | 4 | 5 | 4 | 3 | 5 | 4 |
| Ala | 6 | 6 | 5 | 5 | 7 | 9 | 9 | 6 | 7 | 9 | 6 | 3 | 7 | 12 | 9 |
| Pro | 7 | 4 | 4 | 4 | 7 | 5 | 4 | 6 | 6 | 5 | 5 | 4 | 6 | 7 | 5 |
| Tyr | 4 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 3 | 2 | 1 | 2 | 3 | 2 | 1 |
| Val | 7 | 6 | 4 | 4 | 7 | 6 | 3 | 2 | 7 | 6 | 7 | 4 | 7 | 8 | 7 |
| Ile | 3 | 3 | 2 | 1 | 3 | 2 | 2 | 0 | 4 | 2 | 4 | 2 | 3 | 4 | 3 |
| Leu | 5 | 5 | 4 | 3 | 4 | 5 | 5 | 2 | 4 | 4 | 6 | 4 | 5 | 6 | 5 |
| Phe | 4 | 3 | 2 | 2 | 4 | 2 | 3 | 0 | 4 | 2 | 3 | 2 | 4 | 1 | 1 |
| Lys | 4 | 8 | 8 | 8 | 5 | 5 | 8 | 6 | 5 | 5 | 7 | 5 | 4 | 5 | 4 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| % Hyp 1 | 1.5 | 6.9 | 5.2 | 4.5 | 1.1 | 3.9 | 2.1 | 1.1 | 1.3 | 6.3 | 4.3 | 4.1 | 1.1 | 2.5 | 3.8 |
| % Protein 1 | 7.3 | 25.5 | 17.7 | 13.6 | 6.4 | 16.1 | 7 | 4.4 | 6.8 | 20.5 | 17.4 | 13.1 | 6.2 | 13.7 | 14.6 |
| Hyp/ Protein 2 | 0.2 | 0.27 | 0.29 | 0.33 | 0.17 | 0.24 | 0.3 | 0.25 | 0.19 | 0.31 | 0.25 | 0.31 | 0.18 | 0.18 | 0.26 |
| DW (mg) 3 | 50 | 10 | 8 | 7 | 38 | 10 | 7 | 6 | 51 | 10 | 8 | 7 | 4.6 | 1.6 | 0.75 |
| % Hyp Removed 4 | 6.7 | 39.7 | 54.3 | 10.0 | 62.3 | 83.1 | 7.1 | 45.4 | 54.4 | 10.0 | 10.9 | ||||
| % Protein Removed 4 | 30.1 | 44.5 | 62.3 | 34.4 | 69.6 | 83.6 | 41.1 | 32.1 | 55.3 | 20.0 | 60.9 |
1 % Hyp or Protein: the weight percentage of Hyp and total protein; 2 Hyp/Protein: weight ratio of Hyp in total protein content; 3 DW (mg): the dry weight of cell wall used in HF deglycosylation and the remaining HFI before and after trypsin/pronase digestion; 4 % Hyp or Protein removed: the weight percentage of Hyp and protein removed after HF, trypsin or, pronase digestion calculated from Hyp/protein weight percentage of stepwise HFI, TI HFI and PI HFI.
Figure 1Flow chart outlining the isolation of WT, ANP10 and ANP4 root wall peptides. See Figure 2, Figure 3 and Figure 4 for the peptide maps from the SEC, SCX and reverse-phase HPLC columns.
Figure 2Peptides were isolated from trypsin digested WT HFI using a combination of size exclusion chromatography (SEC) (a), strong cation exchange chromatography (SCX) (b–d) and reverse phase chromatography (e–o), also summarized in Figure 1. Color-coded inserts in panels b to d identify the SEC fractions taken in turn for peptide mapping by SCX. Color-coded inserts in panels e through o identify the SCX fractions taken in turn for further peptide mapping by reverse phase chromatography. Major peptide peaks (A220 > 100) from WT HFI are labeled with “W” while minor peptides are labeled as “WM”.
Figure 3Peptides were isolated from trypsin digested ANP4 HFI using a combination of size exclusion chromatography (SEC) (a); strong cation exchange chromatography (SCX) (b–d) and reverse phase chromatography (e–j); also summarized in Figure 1. Color-coded inserts in panels (b) to (d) identify the SEC fractions taken in turn for further fractionation by SCX chromatography. Color-coded inserts in panels (e) to (j) identify the SCX fractions taken in turn for further peptide mapping by reverse phase chromatography. SCX fractions in (d) failed to yield any peptide peaks on further fractionation by reverse-phase HPLC. The major peptide peaks (A220 > 100) from the ANP4 HFI are labeled with “F” while minor peptides are labeled as “FM”.
Figure 4Peptides were isolated from trypsin digested ANP10 HFI using a combination of size exclusion chromatography (SEC) (a), strong cation exchange chromatography (SCX) (b–d) and reverse phase chromatography (e–j), also summarized in Figure 1. Color-coded inserts in panels b to d identify the SEC fractions taken in turn for further fractionation by SCX chromatography. Color-coded inserts in panels e to j identify the SCX fractions taken in turn for further peptide mapping by reverse phase chromatography. SCX fractions 35 to 37 in (b) and fractions 34 to 37 in (d) failed to yield any peptide peaks on further fractionation by reverse-phase HPLC. The major peptide peaks (A220 > 100) from the ANP10 HFI are labeled with “A” while minor peptides are labeled as “AM”.
HRGPs Identified in WT and ANP Cell Wall HFI.
| Gene Accession # | Protein Identification (Plant Line of Origin) | Peptides Identified (Number of Occurrence in Protein Sequence; Peak of Peptide Identification) 1 | Peptide Mascot Ion Score 2 | Signal Peptide 3 | MM (kDa) 4 | pI 4 | |
|---|---|---|---|---|---|---|---|
| AT1G76930 | EXT1 ( | YYSOOOVYK ( | 1–24 | 32.9 | 10.1 | ||
| HYSOOOVYK ( | |||||||
| SOOOOVK ( | |||||||
| AT1G21310 | EXT3, RSH ( | HYSOOOVYHSOOOOK ( | 1–28 | 49.2 | 10.3 | ||
| SOOOOVK ( | |||||||
| AT3G54580 | EXT17 ( | SOOOOYYSOSOK ( | 54.9 | 1–22 | 105.7 | 9.5 | |
| AT2G43150 | EXT215 ( | SOOOOYYYHSOOOOVK ( | 54.3 | 1–27 | 23.4 | 9.6 | |
| SOOOOVK ( | |||||||
| AT1G12040 | LRX1 ( | LQGPLPSSVGNMK ( | 42.3 | 1–26 | 81 | 8.2 | |
| LLYELDLSNNR ( | 44.5 | ||||||
| AT1G62440 | LRX2 ( | SLEQLNVANNR ( | 71.4 | 89.8 | 4.8 | ||
| LSGPLPSSIGNMK ( | 59.4 | ||||||
| AT4G13340 | LRX3 ( | FNEFEGTVPK ( | 65.9 | 1–20 | 82.2 | 7 | |
| AT3G22800 | LRX6 ( | SLEQLNIAHNK ( | 55.7 | 1–28 | 52.3 | 6.2 | |
| AT3G50580 | HAE2 ( | SOOOOTOK ( | 41.7 | 1–24 | 27.2 | 9.1 | |
| AT2G33790 | AGP30 ( | LPAYPOAK ( | 1–25 | 25.8 | 10.6 | ||
| AT1G28290 | AGP31 ( | SLVAVR ( | 1–25 | 38.4 | 10.8 | ||
| NITAETTTDK ( | |||||||
| AOVSOOAK(O/P)(O/P)VK(O/P)(O/P)VY(O/P)(O/P)TK7 | |||||||
| ( | |||||||
| ( | |||||||
| AT2G04780 | FLA7 ( | FTDVSGTVR ( | 61.4 | 1–22 | 26.8 | 6.5 | |
| AT3G52370 | FLA15 ( | HHFNGEAQVK ( | 42.3 | 1–20 | 48.1 | 6.7 | |
| AT2G35860 | FLA16 ( | EETOATEIKPAAOVVK ( | 55.4 | 1–23 | 49.1 | 6.8 | |
| AT4G38770 | PRP4 ( | EVPO(P/O)VOVYK(P/O)(P/O)(P/O)K7 ( | 1–29 | 49.1 | 10.3 | ||
| IEHPO(P/O)VOVYKOO(P/O)K7 ( | |||||||
| AT5G09530 | PRP10 ( | FPENSKPEVPK ( | 64.8 (in WT) | 1–35 6 | 41.6 | 5.9 | |
| VPEIPKPEETK ( | |||||||
| ( | |||||||
| LPEVPK ( | |||||||
| MPEIPKPELPK (1; AM20) |
1 Only peptides that pass the 95% Scaffold confidence filter are shown; 2 The Mascot ion score are listed for those HRGPs that only have one peptide that pass the 95% Scaffold confidence filter but with score > 40; 3 Signal peptides were predicted by SignalP (www.cbs.dtu.dk/services/SignalP); 4 Predicted protein molecular weight (MM) and isoelectric point (pI) values were obtained from TAIR (www.arabidopsis.org); 5 EXT21 shares one peptide (SOOOOVK) with EXT1 and EXT3, however the Mascot ion score of its unique peptide SOOOOYYYHSOOOOVK is larger than 40, thus validates the existence of EXT21; 6 For PRP10, SignalP prediction indicated the absence of a signal peptide while the cellular localization predicted by TargetP (http://www.cbs.dtu.dk/services/TargetP/) indicated a secretory pathway localization and thus the possession of a signal peptide. The signal peptide sequence and the putative cleavage site were determined according to the S-score (signal sequence score) and C-score (cleavage score) by SignalP; 7 The hydroxylation of some of the Pro residues in some AGP31 and PRP4 peptides could not be precisely determined, thus both possible sequences (either Pro-Hyp or Hyp-Pro) are indicated as P/O.
HRGPs Identified in MT Cell Wall HFI.
| Gene Accession # | Protein Identification | Peptides Identified 1 (Number of Occurrence in Protein Sequence) | Peptide Mascot Ion Score 2 | Total Spectra Count 3 | Signal Peptide 4 | MM (kDa) 5 | pI 5 |
|---|---|---|---|---|---|---|---|
| AT1G76930 | EXT1 | HYSOOOVYK ( | 6 | 1–24 | 32.9 | 10.1 | |
| AT1G21310 | EXT3, RSH | HYSOOOVYHSOOOOK ( | 46.6 | 1 | 1–28 | 49.2 | 10.3 |
| AT2G43150 | EXT21 | SOOOOYYYHSOOOOVK ( | 54.4 | 3 | 1–27 | 23.4 | 9.6 |
| AT1G12040 | LRX1 | KVTVFDITSNR ( | 5 | 1–26 | 81 | 8.2 | |
| AT1G62440 | LRX2 | ELGLLTDLALFHLNSNR ( | 10 | 89.8 | 4.8 | ||
| AT4G13340 | LRX3 | DLDAIFINHNR ( | 11 | 1–20 | 82.2 | 7 | |
| FRFELPENFGDSPVSVIVLANNR ( | |||||||
| AT3G24480 | LRX4 | FPTVVLHLPSLK ( | 11 | 1–25 | 54.7 | 6.9 | |
| AT4G18670 | LRX5 | FAGIFPTVVLQLPSLK ( | 9 | 1–31 6 | 90.8 | 6.7 | |
| AT1G28290 | AGP31 | LFGGDVGAELKPEK ( | 5 | 1–25 | 38.4 | 10.8 | |
| AT2G25060 | PAG2 | LSLVVISPR ( | 44.7 | 1 | 1–28 | 19.5 | 7.4 |
| AT3G62680 | PRP3 | GLTGVPLALYGYR ( | 2 | 1–22 | 34.4 | 9.7 |
1 Only peptides that pass the 95% Scaffold confidence filter are shown; 2 The Mascot ion score are listed for those HRGPs that only have one peptide that pass the 95% Scaffold confidence filter but with score>40.; 3 Total spectra count indicates the relative abundance of protein in the sample; 4 Signal peptides were predicted by SignalP; 5 Predicted protein molecular weight (MM) and isoelectric point (pI) values were obtained from TAIR; 6 For LRX5, SignalP prediction indicated the absence of a signal peptide while the cellular localization predicted by TargetP indicated a secretory pathway localization and thus the possession of a signal peptide. The signal peptide sequence and the putative cleavage site were determined according to the S-score and C-score by SignalP.
Figure 5Comparison of members in HRGP networks of (a) WT and ANPs; (b) MT and ANPs and (c) WT and MT identified by proteomics approach.
Gene Expression Patterns of Proteomics Identified ANP HRGPs using qRT-PCR: A Comparing of WT and rsh Mutant and ANP Revertants.
| Protein (Accession #) | Fold Change (Log2) ANP | Fold Change (Log2) ANP | |
|---|---|---|---|
| ANP4 | EXTs: | ||
| AtEXT1 (AT1G76930) | 0.22; (0.72) 2 | −2.50; (0.00) | |
| AtEXT17 (AT3G54580) | −0.94; (0.13) | 1.03; (0.20) | |
| LRX1 (AT1G12040) | −0.45; (0.29) | 5.35; (0.02) | |
| LRX2 (AT1G62440) | −0.85; (0.05) | −0.66; (0.05) | |
| LRX6 (AT3G22800) | −0.50; (0.30) | −0.95; (0.05) | |
| AGPs: | |||
| AGP31 (AT1G28290) | n/d 3 | n/d | |
| FLA16 (AT2G35860) | n/d | n/d | |
| PRPs: | |||
| PRP4 (AT4G38770) | 1.20; (0.00) | 2.25; (0.00) | |
| PRP10 (AT5G09530) | −0.55; (0.05) | 3.30; (0.01) | |
| ANP10 | EXTs: | ||
| AtEXT1 (AT1G76930) | 0.40; (0.04) | −1.69; (0.001) | |
| LRX1 (AT1G12040) | −0.07; (0.86) | 6.90; (0.0001) | |
| LRX2 (AT1G62440) | −0.07; (0.79) | 0.89; (0.01) | |
| LRX3 (AT4G13340) | 0.64; (0.02) | −2.27; (0.0003) | |
| HAE2 (AT3G50580) | 3.33; (0.02) | 0.14; (0.77) | |
| AGPs: | |||
| AGP31 (AT1G28290) | n/d | n/d | |
| PRPs: | |||
| PRP10 (AT5G09530) | −1.33; (0.00) | 3.7; (7.9 × 10−6) |
1 The culture generation compared: ANP4/10-F3 vs. WT-F2, ANP4-F2 vs MT-F1 and ANP10-F3 vs. MT-F1; 2 Numbers in parenthesis: significance value, p ≤ 0.05 are considered statistically significant; 3 n/d: not determined.